Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT02046070 · COMPLETED
Trial details
- NCT number
- NCT02046070
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-05
- Primary completion
- 2018-06-29
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.